Northallerton carer calls for greater support for unpaid carers
A mum who quit her job to care for her father and daughter has called on the government to provide better support for carers.Rachel, 43, from Northallerton, quit her career in catering after her father, Michael, was diagnosed with terminal cancer eight years ago.She moved into his home with her two daughters to care for him – and has warned it would cost the government a lot of money if people like her did not take on caring responsibilities.A government spokesperson said they recognised the "immense contribution" of unpaid carers and an independent review had been launched into social care.
Rachel also looks after her two daughters who have health issues."If I'm not there helping out my dad and my daughters, there would be more hospital admissions and it would cost government a lot more," she said."I feel I couldn't take paid employment and still be a carer."Thankfully my dad is still with us and his condition is well managed, but his health can fluctuate quickly – that has to be my priority and I can't put that burden on an employer, it wouldn't be fair."
Rachel began caring for her dad Michael when her daughter Lillian was a newborn baby and her own mum died suddenly at the age of 61."At first you just go into survival mode of battling to help him stay alive, so Lillian learnt to walk on the chemo ward," she said."It became clear my dad had been far too well looked after. He had never used a washing machine nor had to manage a household, so I made the decision that it would be better for me to be there."Michael, who is still able to work three days a week, said he felt fortunate to have a professional career.He said: "We're not financially embarrassed by this, but, equally, Rachel has given up her chances of a career throughout her life."Hopefully that will be picked up later on. But there's no compensation from the government or acknowledgement."
'Careers derailed'
According to charity Carents, thousands of people across Yorkshire have cut short their careers to look after their parents.A survey of 1,000 carers, conducted by the organisation, claimed 70% had needed to alter their jobs due to caring responsibilities.Carents is a national charity created to support unpaid adult carers, founded by Dr Jackie Gray.She said: "Our figures show the staggering scale in which adults are having their careers derailed due to the their caring duties."It shouldn't and doesn't have to be this way, and it is vital that there is more support provided to adult carers for them to care alongside their career, rather than in place of it."A government spokesperson said an independent review had been launched into social care to explore the needs of unpaid carers.They said: "We recognise the immense contribution of carers who selflessly dedicate their time to supporting others."We want families to receive the support they deserve, which is why we have increased the Carer's Allowance earnings threshold by around an additional £2,000 a year – the biggest rise since it was introduced in 1976."
Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
I was diagnosed with Alzheimer's after ‘overused' medical procedure caused my dementia
Sean Fischer's mother had been getting sicker for decades. She would ask the same question multiple times, be bedbound from migraines and unstable on her feet. The mystery behind her decades-long ailments was seemingly solved when she was diagnosed with Alzheimer's disease in June 2022. Sean said: 'We had spent countless hours fretting over what could be wrong, but not once did I think it could be early-onset Alzheimer's. That diagnosis belongs to other families, I thought. Not ours.' The Fischers met with renowned neurologists and prepared the then-61-year-old to participate in an Alzheimer's clinical trial for the drug varoglutamstat. Then came devastating news that meant Mrs Fischer wouldn't be eligible for the trial - she was suffering from a persistent leak of spinal fluid somewhere in her spinal system, but doctors couldn't pinpoint the source - and couldn't fix it. They believed it was likely a result of epidurals she'd received during childbirth - an injection in the back that numbs a person from their belly button to their thighs. It's a common pain relief option during childbirth and an estimated 61 percent of women who give birth receive an epidural. After suffering for more than a decade, doctors said a new procedure would allos them to inject dye into Mrs Fischer's spinal fluid to search for the leak - a small spot in the middle of her back. A few weeks after they sealed it, all of her symptoms went away and doctors said she didn't actually have Alzheimer's - the tiny spot in her back was actually the source of all her symptoms. Mrs Fischer's health battle began long before her Alzheimer's diagnosis. It started in spring 2001, when Sean said he received a call from his dad: Mom had pulled over on the highway, vomiting from a sudden, crushing headache. Her doctor called it a migraine, but months later she lost hearing in one ear and was diagnosed with Ménière's disease. She adjusted — avoiding movements that triggered vertigo, wearing a hearing aid in her forties, and taking daily meds for the headaches. Even as she quietly suffered, Sean wrote for The Free Press, she stayed steady for him and his brothers, never missing a soccer game, school musical, or packed lunch. In 2010, neurologists at Columbia University diagnosed her with a Chiari malformation, a structural defect where the brain is pushed through the opening at the base of the skull. They suspected the malformation was caused by a cerebrospinal fluid leak, sparked by her three epidurals from the births of each of her sons. Epidurals are extremely safe and are administered by inserting a needle in the space of the lower spine just outside the membrane that surrounds the spinal cord. It delivers anesthetic medication, which numbs the lower half of the body and blocks pain while allowing the patient to stay awake and alert. However, it can occasionally result in a leak if the needle punctures the thin, tough membrane surrounding the spinal cord containing the CSF, called the dura mater. When this happens, some of the fluid that cushions and protects the brain and spinal cord can leak out into surrounding tissues. It can only be patched up surgically. The leak had, over the years, led to a loss in cerebrospinal fluid volume, causing her brain to sink. This can lead to severe headaches, nausea and vomiting, hearing changes, memory problems, and double vision. 'I started high school in 2015, and around that time, I began to notice the quiet dislocation of my mom's mind,' Sean wrote for The Free Press. 'When we cooked dinner together, she would have trouble following recipes. She'd stare at her calendar for long stretches of time; making sense of it seemed to require more effort than usual. She started to repeat herself. 'By the time I left for college in Rhode Island, the phrase 'You already asked me that' had become a common refrain in the house I grew up in, but at first, we blamed her, telling her she needed to pay more attention.' She was seeing doctors for headaches, hearing, and anxiety, none of whom believed there could be a common origin. Her memory problems were worsening as well, which led to Mr and Mrs Fischer to to turn to NYU Langone Health's Center for Cognitive Neurology. 'My mom was tested extensively — and two months later came the diagnosis, with the finality of a punctuation mark. Alzheimer's. When it hit her that there was no cure, my mom was bedridden for three days,' Sean said. Hope came with the study. But then doctors called the Fischers and informed them that the CSF leak would not allow her to participate. Despair took over. But a few weeks later, Mrs Fischer's doctor called to tell them about recent medical innovations that would allow surgeons to find and fix the leak, allowing her to participate in the drug trial. Six months later, doctors inserted a probe through the femoral artery in Mrs Fischer's leg, fed it upward toward her spinal system, and sealed the leak. Sean said: 'Two weeks later, I visited home, and found Mom more alert than she had been in years. There was no absent look in her eyes. As the day went on, I waited for her to start fading—but she was still wide awake at 10 p.m. 'After three weeks, her vertigo was gone, and her physical therapist told her she didn't need treatment anymore, because she no longer had any balance problems. After four weeks, she told us she felt 20 years younger.' After six weeks, her problems with memory were gone entirely. 'And eventually, Mom's neurologist confirmed: She did not have Alzheimer's. The surgeons who fixed the leak were shocked. They had never seen a recovery like it,' Sean said. The family later learned that, a year before the procedure, Cedars-Sinai Medical Center had published a newsletter with the subtitle: 'Physicians Treating Dementia Should Look for Cerebrospinal Fluid Leak—A Treatable Cause of an Otherwise Incurable Condition.' The study followed 21 patients with headaches, severe fatigue, and diagnoses of Chiari malformation and dementia; nine were found to have a cerebrospinal fluid leak, and repairing it completely resolved their symptoms. In Sean's mother's case, countless specialists across multiple hospitals treated her symptoms in isolation, overlooking the root cause. But they chose not to place blame on any doctor or institution. It was the system that misdiagnosed her, and ultimately, the system that saved her. 'More than anything, we feel grateful that a scientific breakthrough came at just the right time; that the real cause of her suffering was found,' he said.
Times
an hour ago
- Times
What can a £5,000 at-home laser do?
With the beauty-gadget industry growing at four times the rate of the overall skincare category, with sales projected to hit $92.55 billion by 2028, it seems to be becoming the favoured option for people who want the results of a visit to the aesthetician, but prefer less invasive approaches. • This article contains affiliate links that can earn us revenue As a result the British wellness brand LYMA is doing better than ever. Founded in 2018, its initial offering was the LYMA supplement, a gold-coloured capsule containing active ingredients formulated to be bioavailable and therefore fully absorbed by the body. Despite coming at a price — around £199 for a month's supply — the pills frequently sold out and were nicknamed the 'supermodel supplement' to those in the wellness world. Unsurprisingly, LYMA loyalists were thrilled when LYMA dropped its first at-home clinic-grade laser in 2020, the launch helped LYMA receive a 40 per cent increase in turnover to £32.5 million, with US sales accounting for 70 per cent of their total revenues. Now the range includes both the original LYMA laser as well as the LYMA Laser Pro which launched in March 2024. Both use technology called low-level laser therapy (LLLT) first developed in the 1960s which was previously used to treat medical injuries such as healing tendons and rebuilding cartilage. The founder of LYMA, Lucy Goff, decided to harness this existing technology and re-engineer it for the cosmetic market, creating a portable, cordless device that could be used at home without the supervision of a doctor or a prescription*. Goff consulted geneticists, longevity scientists and surgeons and spent five years developing the laser. In contrast to some other cosmetic procedures which have to deliver micro-injury to the skin and inflict damage in order to create collagen, the LYMA lasers utilise powerful, zero-damage cold laser technology. The original iteration is a smaller, handbag-sized device that features a patented 8cm² treatment lens, primarily designed for the face. The LYMA Laser Pro can also be used on the neck and body, and has cut down the initial treatment time of 15 minutes per day to just three minutes per area of concern (such as cheeks, forehead and eye areas), or a full face in as little as 9 minutes, thanks to its larger 30cm² lens. Dr Graeme Glass, a craniofacial, aesthetic and plastic surgeon and now the director of aesthetics at LYMA, helped develop the laser and has written several medical papers on its technology. With many women losing fat through the rise of Ozempic and other weight loss alternatives, Glass recommends the LYMA laser. 'Losing weight can be associated with the loss of subcutaneous fat which can give the appearance of laxity as the face and neck structures hang on relatively loose ligaments,' he says. 'The skin loses its lustre because of loss of water content in the dermis, lack of synthesis of the protective fatty acids that condition the skin, and lack of vitamins and minerals essential for healthy skin function.' Just like the rest of our body, our skin needs energy function, which usually comes in the form of ATP (adenosine triphosphate) to help the skin stay hydrated, produce collagen and elastic, as well as promote cell renewal. Without enough ATP, the skin becomes dull and will start to sag or age at a faster rate, Glass explains. To counteract this, the LYMA laser uses the technique of low level laser therapy using near-infrared light. According to LYMA's website: 'this light triggers a natural process in your cells called photobiomodulation, which helps your skin produce ATP more efficiently. It's like charging up the skin's internal battery, so it has the energy it needs to repair and regenerate itself.' LYMA claims that over time the ATP produced through using the laser will help boost collagen and elastin production — both key for the appearance of firmer, smoother skin. The brand promises an improvement in as little as 30 days with daily use and recommends following with twice weekly sessions as maintenance. LYMA's own clinical trials involving 10 subjects showed 64.3 per cent improvement in pigmentation, a 53.8 percent improvement in wrinkles, a 42 per cent improvement in rosacea symptoms, and a 56 per cent decline in acne and blemishes.** At around £1,999 and around £4,995 respectively, the LYMA lasers are undoubtedly an expensive piece of kit, but that hasn't kept customers away. LYMA sold 47 per cent more stock than predicted in the first 24 hours of its US launch and counts a whole host of celebrities, including Sienna Miller and Gwyneth Paltrow, as loyal users. Likewise, the launch of LYMA skincare, a duo of anti-ageing serum and creams, had a waitlist of around 30,000 expectant customers. But it's the Laser Pro which is helping the brand put a stake in the ground of the $211 billion global professional beauty services market — and a pretty big stake at that. * LYMA's policy outlines if you have a recurring or previously diagnosed health condition that concerns you, or are taking prescription medication, upon purchase of our products you agree to seek medical advice from your GP before taking our products and/or making dietary and lifestyle changes. **Based on an independent clinical trial measured by Cutometer dual MPA 580 — a device used to measure skin elasticity and firmness by assessing the skin's ability to deform and return to its original shape, plus LYMA's own studies which can be found here.
The Independent
2 hours ago
- The Independent
Families of Nottingham attack victims to hold memorial walk two years on
The families of the Nottingham attack victims will hold a memorial walk to remember their loved ones two years after their deaths. The relatives of 19-year-old students Grace O'Malley-Kumar and Barnaby Webber and 65-year-old caretaker Ian Coates will meet at St Paul's Church in Lenton Road at 11.30am on Friday before walking to the two locations of the attacks. They say this is 'to show respect for the horror that their loved ones endured at the hands of this monster', to 'wish them peace for wherever they may now be' and 'mark the importance of their fight for justice'. Mr Webber's mother Emma Webber said: 'We will lay flowers, with our love and memories of three wonderful human beings.' The walk, which is set to last 90 minutes, is open to the public and participants will wear green and gold for the University of Nottingham, where Ms O'Malley-Kumar and Mr Webber were studying, and red for Mr Coates's beloved Nottingham Forest. Valdo Calocane, who had been diagnosed with paranoid schizophrenia, killed them and attempted to kill three more people in Nottingham on June 13 2023. He was sentenced to an indefinite hospital order in January 2024 after admitting manslaughter by diminished responsibility and attempted murder. A February report into the care received by Calocane said he was not forced to have long-lasting antipsychotic medication because he did not like needles, and other patients at Nottinghamshire Healthcare NHS Foundation Trust also went on to commit 'extremely serious' acts of violence. Prosecutors, police and medical professionals will be scrutinised in a two-year inquiry, including the Independent Office for Police Conduct (IOPC). Sharon Miller and Wayne Birkett, survivors of the attacks, said in a statement that a 'collective, united effort' is needed to improve the effectiveness of local public services and prevent future tragedies. Their statement read: 'On this two-year anniversary, we remember those we lost and look to the future with hope – hope that lessons will be learned and meaningful change and action will follow. 'We are grateful to the bereaved families for inviting us to the memorial walk they have so thoughtfully arranged.'
